Case Reports in Infectious Diseases

Case Reports in Infectious Diseases / 2019 / Article

Case Report | Open Access

Volume 2019 |Article ID 1094837 | 4 pages |

Emphysematous Aortitis due to Clostridium septicum in an 89-Year-Old Female with Ileus

Academic Editor: Gernot Walder
Received01 Apr 2019
Revised22 Jun 2019
Accepted21 Jul 2019
Published27 Aug 2019


Emphysematous aortitis is a rare but lethal form of infectious vasculitis. This condition was found incidentally on computed tomography of the chest during the evaluation of a patient presenting with pneumonia coincident with adynamic ileus. The patient did not have a history of malignancy. While colon cancer could not be ruled out, it is possible that ileus may have contributed to or resulted in bacterial translocation in this case. Appropriate investigations and empirical therapy against Clostridium septicum should be initiated in the presence of clinical and radiological findings suggestive of emphysematous aortitis.

1. Introduction

Emphysematous aortitis (EA) is a rare form of vasculitis with a nonspecific clinical presentation and high fatality rates. Malignancy, which is a frequent finding in these patients, causes loss of integrity of the intestinal mucosa, facilitating Clostridium septicum (CS) bacteremia and infection at distant sites. Adynamic ileus may also cause bacteremia through similar mechanisms. This observation underscores the need to consider other less common mechanisms of bacterial translocation during the assessment of EA due to CS.

2. Case Description

An 89-year-old female was admitted to our institution after three days of subjective fevers, dyspnea, productive cough, malaise, and anorexia. She denied having chest or back pain. Medical history included hypertension, hyperlipidemia, type 2 diabetes mellitus, and stage 4 chronic kidney disease, with no history of surgical interventions or toxic habits. Diverticulosis and a 6 mm sigmoid hyperplastic polyp which was completely removed were identified on colonoscopy five years earlier.

On exam, the patient’s temperature was 99.0°F, heart rate 108/min, respiratory rate 30/min, blood pressure 148/100 mmHg, and oxygen saturation 92% on 2 liters of oxygen via nasal cannula. She appeared ill. Bilateral inspiratory crackles and decreased breath sounds at the left lung base were auscultated. Her abdomen was distended, and bowel sounds were absent. The physical exam was otherwise unremarkable.

Significant laboratory findings included leukocytosis of 26.8 K/μL with neutrophilia (81%), creatinine of 3.32 mg/dL, and normal lactic acid at 1.5 mmol/L. Fecal occult blood testing was negative. A chest radiograph revealed a tortuous, calcified aorta and a left pleural effusion with adjacent infiltrates (Figure 1). Abdominal X-ray revealed diffuse gaseous distension of the bowel consistent with ileus (Figure 2). Abdominal ultrasound was significant only for multiple gallstones. The visualized abdominal aorta was unremarkable. No suspicious bowel lesions were observed. Computed tomography (CT) of the chest revealed left lung infiltrates and a moderate left pleural effusion. Incidentally, numerous foci of soft tissue gas were noted within the aortic wall, extending from the arch to the distal descending aorta (Figure 3(a)). Treatment for emphysematous aortitis and pneumonia in a patient with penicillin allergy was initiated with intravenous vancomycin, aztreonam, and clindamycin, especially to cover anaerobes such as clostridial species.

Cardiothoracic surgery consultation was obtained. However, the patient was not considered a surgical candidate since she was clinically unstable, having developed atrial fibrillation with rapid ventricular response and hypertensive crisis at this time, requiring transition of care to the intensive care unit.

The patient was eventually stabilized and transitioned to the general medicine ward. CS was subsequently isolated in the first three consecutive anaerobic blood culture bottles. Pleural fluid obtained five days after admission was exudative, with pleural fluid to serum protein ratio greater than 0.5 and pleural fluid to serum lactate dehydrogenase (LDH) ratio greater than 0.6 (pleural fluid: glucose 159 mg/dL, total protein 3.7 g/dL, and LDH 258 IU/L; plasma: glucose 127 mg/dL, total protein 5.9 g/dL, and LDH 312 IU/L). Pleural fluid cultures were negative. On admission day 10, a follow-up chest CT showed fluid and inflammatory changes replacing the gas pockets seen on the initial study (Figure 3(b)). CT imaging of the abdomen with intravenous contrast was considered as a noninvasive alternative to evaluate the presence of any intra-abdominal malignancy since the patient was not stable to undergo colonoscopy. However, the patient’s renal function precluded the use of this imaging modality. Upon discussion of the condition, its management, and prognosis with the patient and her healthcare proxy, the decision was made to transition the patient’s care to hospice. Colonoscopy was therefore not pursued, and after 12 days of intravenous antibiotics, a 6-week course of oral clindamycin was prescribed at the time of discharge. It has not been possible to confirm whether and for how long the patient survived after this.

3. Discussion

CS is an opportunistic, Gram-positive, spore-forming anaerobe, found in any habitat with organic compounds. Notably, it causes atraumatic gas gangrene with myonecrosis resulting from the release of hyaluronidase, hemolysin, lethal necrotizing and other toxins [1]. Occurrence of spontaneous gas gangrene by CS is usually tied to conditions leading to either enhanced bacterial invasiveness, increased host vulnerability to infection, or both. Mucosal changes observed in colitis and colon cancer result in low pH, hypoxia, and increased lactate concentrations in affected tissue [2, 3]. CS spores proliferate under these conditions, which are also conducive to the development of intestinal ulcerations through which CS may enter the bloodstream [4]. Malignancy and diabetes are, respectively, the first and second most frequent conditions associated with atraumatic gas gangrene [5]. Overall, CS infections are unusual, representing approximately 1.3% of all caused by Clostridia [6].

Infectious aortitis is a rare entity, accounting for 2.6% of aortic aneurysms [7]. CS is the most common causal agent. Risk factors include a history of prior vascular instrumentation, atherosclerosis, and colon cancer, which has been reported in 82.5% of cases [5]. In other cases, EA has been associated with Crohn’s disease [8], ulcerative colitis [9], diverticulosis [10], and benign polyps [11]. It has also been observed in patients without neoplastic disease including young, otherwise healthy individuals [1215]. CS-relative aerotolerance facilitates its ability to invade well-oxygenated tissue, leading to the rapid development of an infected aneurysm [1]. Clinical features are often nonspecific and include fever, chills, and pain localized to the chest, back, or abdomen [7]. Early diagnosis can be usually made with CT, which shows periaortic gas in 92.6% of cases. Treatment involves surgery and intravenous antibiotics. In cases where surgery is performed electively, a course of antibiotics precedes the intervention, which is then followed by at least six weeks of intravenous antibiotics. This course could then be followed by life-long oral-suppressive antibiotic therapy [5]. Antibiotics should be initiated as soon as suspicious lesions are identified with high-dose penicillin plus clindamycin, which is thought to prevent toxin synthesis [16]. Metronidazole and vancomycin could be used as alternative agents in those allergic to penicillin [1]. The overall 6-month mortality associated with CS EA is 79.5%, which increases to 100% if no surgery is performed [5].

Contrasting with most cases, our patient had no history of aortic instrumentation. The case also highlights the utility of CT in early diagnosis since periaortic gas was visualized days before CS was isolated. Since the patient had two distinct infectious processes and a history of penicillin allergy, antibiotic selection was guided by the need to cover against anaerobic, Gram-positive, and Gram-negative bacteria.

The inability to exclude the presence of gastrointestinal malignancy represents a limitation of this case study. As indicated in the case description, the patient’s critical condition at presentation, renal failure, and subsequent request for the provision of hospice care precluded further investigations in this regard. A review of the patient’s health records showed that no suspicious masses were found on noncontrast CT studies of the abdomen and pelvis obtained within two years prior to this admission. Regarding her colonoscopy findings, it appears that small rectosigmoid hyperplastic polyps are not associated with an increased risk of colorectal cancer [17, 18], and guidelines recommend surveillance colonoscopy in 10 years from the baseline study [19]. While malignancy could not be conclusively ruled out, the above considerations, together with the absence of weight loss, anorexia, a negative fecal occult blood testing at presentation, and the nonvisualization of sizable intestinal masses on ultrasound, may suggest the presence of colorectal cancer was less likely. As noted above, both diverticula and benign polyps, which were found on the patient’s colonoscopy, have been associated with EA and could have contributed to the occurrence of bacteremia in this case. In addition, the patient’s diabetes and extensive atherosclerosis are by themselves significant risk factors associated with EA.

An interesting consideration in this case concerns the potential association between CS bacteremia and adynamic ileus, which may have resulted from the left lower lobe pneumonia. As seen with colitis and malignancy, ileus can induce local ischemia-reperfusion injury, microvascular thrombosis, and inflammatory changes causing mucosal ulcerations, damage to the mucosal-associated lymphoid tissue, and impairment of other local protective mechanisms [20]. In addition, bacterial overgrowth leads to intraluminal nutrient depletion. The resultant dysbiosis eliminates the protective role of the normal intestinal flora, with a predominance of anaerobes such as Bacteroides and Clostridium. Finally, pathogenic virulence factors activate local and systemic inflammatory responses, affecting host immunity and giving way to bacterial translocation into the lymphatic and venous circulation through mucosal defects [2025].

4. Conclusion

CS aortitis is rare and lethal. While its clinical presentation is usually nonspecific, emphysematous aortitis should be included in the differential diagnosis of patients presenting with systemic signs of infection and nonspecific chest or back pain, abdominal discomfort, and a history of aortic atherosclerosis, diabetes, and/or colon cancer. In their assessment, clinicians should be alert to the possibility that other conditions such as colitis, diverticulosis, benign polyps, and possibly ileus may create lesions serving as potential ports for bacteria to enter the circulation. Finally, considering that an aneurysm may appear only at more advanced stages of the infection, it would be reasonable to evaluate the aorta with CT imaging upon isolation of CS in blood cultures of otherwise asymptomatic patients, to rule out the presence of incipient EA.

Written consent for this case report was obtained from the patient’s healthcare proxy.


The case was presented at the 14th Annual MSSNY Resident/Fellow and Medical Student Poster Symposium.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.


  1. I. Srivastava, M. J. Aldape, A. E. Bryant, and D. L. Stevens, “Spontaneous C. septicum gas gangrene: a literature review,” Anaerobe, vol. 48, pp. 165–171, 2017. View at: Publisher Site | Google Scholar
  2. J. R. Koransky, M. D. Stargel, and V. R. Dowell Jr., “Clostridium septicum bacteremia its clinical significance,” The American Journal of Medicine, vol. 66, no. 1, pp. 63–66, 1979. View at: Publisher Site | Google Scholar
  3. S. S. B. Chew and D. Z. Lubowski, “Clostridium septicum and malignancy,” ANZ Journal of Surgery, vol. 71, no. 11, pp. 647–649, 2001. View at: Publisher Site | Google Scholar
  4. R. J. Alpern and V. R. Dowell Jr., “Clostridium septicum infections and malignancy,” JAMA: The Journal of the American Medical Association, vol. 209, no. 3, pp. 385–388, 1969. View at: Publisher Site | Google Scholar
  5. F. Ito, R. Inokuchi, A. Matsumoto et al., “Presence of periaortic gas in Clostridium septicum-infected aortic aneurysm aids in early diagnosis: a case report and systematic review of the literature,” Journal of Medical Case Reports, vol. 11, no. 1, p. 268, 2017. View at: Publisher Site | Google Scholar
  6. A. A. Kornbluth, J. B. Danzig, and L. H. Bernstein, “Clostridium septicum infection and associated malignancy,” Medicine, vol. 68, no. 1, pp. 30–37, 1989. View at: Publisher Site | Google Scholar
  7. R. J. Lopes, J. Almeida, P. J. Dias, P. Pinho, and M. J. Maciel, “Infectious thoracic aortitis: a literature review,” Clinical Cardiology, vol. 32, no. 9, pp. 488–490, 2009. View at: Publisher Site | Google Scholar
  8. M. M. Foga, G. J. McGinn, M. A. Kroeker, and R. Guzman, “Sepsis due to Clostridium septicum: case report,” Canadian Association of Radiologists Journal, vol. 51, no. 2, pp. 85–89, 2000. View at: Google Scholar
  9. G. Tokmaji, I. Gosev, K. K. Kumamaru, and R. M. Bolman, “Mycotic aneurysm of the aortic arch presenting with left vocal cord palsy,” The Annals of Thoracic Surgery, vol. 96, no. 1, pp. 302–305, 2013. View at: Publisher Site | Google Scholar
  10. N. Annapureddy, S. K. Agarwal, V. Kanakadandi et al., “Clostridium septicum aortitis in a patient with extensive atheromatous disease of the aorta,” Journal of Infection and Chemotherapy, vol. 18, no. 6, pp. 948–950, 2012. View at: Publisher Site | Google Scholar
  11. D. P. Murphy, D. B. Glazier, and T. J. Krause, “Mycotic aneurysm of the thoracic aorta caused by Clostridium septicum,” The Annals of Thoracic Surgery, vol. 62, no. 6, pp. 1835–1837, 1996. View at: Publisher Site | Google Scholar
  12. D. M. Sailors, J. F. Eidt, P. J. Gagne, R. W. Barnes, G. W. Barone, and D. R. McFarland, “Primary Clostridium septicum aortitis: a rare cause of necrotizing suprarenal aortic infection,” Journal of Vascular Surgery, vol. 23, no. 4, pp. 714–718, 1996. View at: Publisher Site | Google Scholar
  13. J. Christensen and C. Bistrup, “Emphysematous pyelonephritis caused by Clostridium septicum and complicated by a mycotic aneurysm,” The British Journal of Radiology, vol. 66, no. 789, pp. 842-843, 1993. View at: Publisher Site | Google Scholar
  14. Z. Yang and S. D. Reilly, “Clostridium septicum aortitis causing aortic dissection in a 22-year-old man,” Texas Heart Institute Journal, vol. 36, no. 4, pp. 334–336, 2009. View at: Google Scholar
  15. F. Eplinius and C. Hädrich, “Acute aortic dissection caused by Clostridium septicum aortitis,” Forensic Science International, vol. 244, pp. e38–e41, 2014. View at: Publisher Site | Google Scholar
  16. D. L. Stevens, K. A. Maier, and J. E. Mitten, “Effect of antibiotics on toxin production and viability of Clostridium perfringens,” Antimicrobial Agents and Chemotherapy, vol. 31, no. 2, pp. 213–218, 1987. View at: Publisher Site | Google Scholar
  17. A. O. Laiyemo, G. Murphy, L. B. Sansbury et al., “Hyperplastic polyps and the risk of adenoma recurrence in the polyp prevention trial,” Clinical Gastroenterology and Hepatology, vol. 7, no. 2, pp. 192–197, 2009. View at: Publisher Site | Google Scholar
  18. S. P. Bensen, B. F. Cole, L. A. Mott, J. A. Baron, R. S. Sandler, and R. Haile, “Colorectal hyperplastic polyps and risk of recurrence of adenomas and hyperplastic polyps,” The Lancet, vol. 354, no. 9193, pp. 1873-1874, 1999. View at: Publisher Site | Google Scholar
  19. D. A. Lieberman, D. K. Rex, S. J. Winawer, F. M. Giardiello, D. A. Johnson, and T. R. Levin, “Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US multi-society task force on colorectal cancer,” Gastroenterology, vol. 143, no. 3, pp. 844–857, 2012. View at: Publisher Site | Google Scholar
  20. B. Y. De Winter and J. G. De Man, “Interplay between inflammation, immune system and neuronal pathways: effect on gastrointestinal motility,” World Journal of Gastroenterology, vol. 16, no. 44, pp. 5523–5535, 2010. View at: Publisher Site | Google Scholar
  21. J. MacFie, “Current status of bacterial translocation as a cause of surgical sepsis,” British Medical Bulletin, vol. 71, no. 1, pp. 1–11, 2004. View at: Publisher Site | Google Scholar
  22. C. Madl and W. Druml, “Systemic consequences of ileus,” Best Practice & Research Clinical Gastroenterology, vol. 17, no. 3, pp. 445–456, 2003. View at: Publisher Site | Google Scholar
  23. D. Stankovid-Đorđevid, N. Đorđevid, G. Tasid, M. Dinid, and M. Bogdanovid, “Role of bacteria in intestinal obstruction pathophysiological processes,” Facta Universitatis, vol. 13, no. 3, pp. 127–132, 2006. View at: Google Scholar
  24. L.-A. Ding and J.-S. Li, “Intestinal failure: pathophysiological elements and clinical diseases,” World Journal of Gastroenterology, vol. 10, no. 7, pp. 930–933, 2004. View at: Publisher Site | Google Scholar
  25. S. Balzan, C. de Almeida Quadros, R. de Cleva, B. Zilberstein, and I. Cecconello, “Bacterial translocation: overview of mechanisms and clinical impact,” Journal of Gastroenterology and Hepatology, vol. 22, no. 4, pp. 464–471, 2007. View at: Publisher Site | Google Scholar

Copyright © 2019 Susana Urgiles et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

409 Views | 184 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.